A Consensus Decision Pathway for Optimizing Care for Heart Failure

Guidance with respect to pivotal clinical questions in the care of patients with heart failure

Sponsoring Organization: American College of Cardiology

Background and Objective

The evidence for treating heart failure, particularly with reduced ejection fraction (HFrEF), has evolved substantially since the publication in 2017 of the most recent guideline from the American College of Cardiology and American Heart Association (ACC/AHA) and the ACC Expert Consensus Decision Pathway.

Key Points

The document addresses the following crucial issues:

Initiating, adding, or switching evidence-based therapies for HFrEF, with a focus on initiating angiotensin receptor/neprilysin inhibitors (ARNIs), incorporating sodium–glucose cotransporter-2 (SGLT-2) inhibitors, and considering transcatheter mitral-valve repair
Achieving optimal guideline-directed the…

Reviewing Author

Frederick A. Masoudi, MD, MSPH, FACC, FAHA

Disclosures

Consultant/Advisory BoardBristol Myers Squibb; CPC Clinical Research

Grant/Research SupportNational Heart, Lung, and Blood Institute

Editorial BoardsUpToDate; American College of Cardiology Self-Assessment Program (SAP)

Leadership Positions in Professional SocietiesAmerican College of Cardiology (Chair, Innovations Committee)